Toloxatone
Toloxatone is a selective and reversible monoamine oxidase A (MAO-A) inhibitor that prevents the oxidative deamination of serotonin and norepinephrine, increasing their synaptic concentrations and producing antidepressant effects. It is used for the treatment of depression and has the advantage over irreversible MAO inhibitors of lower risk for tyramine-induced hypertensive crisis (cheese effect) due to its reversibility and selectivity. Its RIMA (reversible inhibitor of MAO-A) profile allows competitive displacement by dietary tyramine, reducing the dietary restrictions required.
分子量
207.2300 g/mol
LogP
1.20
TPSA
49.80 Ų
リピンスキーの五則
適合
Pharmacokinetics (PK)
Pharmacodynamics (PD)
2D構造
Cite this structure
Embed this structure
SMILES
Cc1cccc(N2CC(CO)OC2=O)c1
InChI
InChI=1S/C11H13NO3/c1-8-3-2-4-9(5-8)12-6-10(7-13)15-11(12)14/h2-5,10,13H,6-7H2,1H3
Molecular Formula
C11H13NO3
HBD / HBA
1 / 3
回転可能結合数
2
重原子数
15
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
よくある質問
Toloxatone is a selective and reversible monoamine oxidase A (MAO-A) inhibitor that prevents the oxidative deamination of serotonin and norepinephrine, increasing their synaptic concentrations and producing antidepressant effects. It is used for the treatment of depression and has the advantage over irreversible MAO inhibitors of lower risk for tyramine-induced hypertensive crisis (cheese effect) due to its reversibility and selectivity. Its RIMA (reversible inhibitor of MAO-A) profile allows competitive displacement by dietary tyramine, reducing the dietary restrictions required.
Yes, Toloxatone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL18116. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 34521. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="toloxatone"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/toloxatone/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/toloxatone/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/toloxatone/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="toloxatone"></drugfyi-drug>